CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) was identified by our screener as a strong growth stock with a favorable technical setup. The company combines solid fundamentals with a promising chart pattern, making it worth a closer look.
Fundamental Strengths
Growth: CPRX has demonstrated strong revenue and earnings growth, with EPS increasing by 112.16% over the past year and revenue growing by 29.96%. Future earnings are expected to rise by 29.40% annually.
Profitability: The company boasts a Profit Margin of 36.91%, outperforming 97.67% of its biotechnology peers. Its Return on Equity (24.85%) and Return on Invested Capital (21.96%) are also industry-leading.
Financial Health: With no debt and a Current Ratio of 6.14, CPRX maintains a strong balance sheet. Its Altman-Z score of 16.67 indicates low bankruptcy risk.
Valuation: Despite strong growth, CPRX trades at a P/E of 13.89, significantly below both industry and S&P 500 averages.
Technical Setup
While the stock’s short-term trend is negative, it presents a consolidation pattern with potential for a breakout:
Support Zones: Key support levels are found at $20.58-$21.02 and $19.56, providing downside protection.
Resistance Levels: A breakout above $21.82-$22.11 could signal upward momentum.
Setup Rating: The stock earns an 8/10 for its technical setup, suggesting a possible entry point if resistance is breached.